The role of Toll-like receptors in combating mycobacteria

Seminars in Immunology

Volumn 16, Issue 1, 2004, Pages 35-41

  Krutzik, Stephan R ^a   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Innate immunity; Intracellular; Mycobacteria; TLR; Toll

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GLYCAN DERIVATIVE; LIPOPROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CELL ACTIVATION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL;

EID: 0742272507     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.10.005     Document Type: Article

References (64)

1. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
2. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R.et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science. 285:1999;732-736.
3. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:1999;3920-3927.
4. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H.et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
5. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:2001;732-738.
6. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R.et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 410:2001;1099-1103.
7. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K.et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:2002;196-200.
8. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H.et al. HumanTLR7 orTLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3:2002;499.
9. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A.et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science. 291:2001;1544-1547.
10. Hertz C.J., Kiertscher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D.et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2m. J. Immunol. 166:2001;2444-2450.
11. Morris K.R., Lutz R.D., Choi H.S., Kamitani T., Chmura K., Chan E.D. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect. Immun. 71:2003;1442-1452.
12. Jones B.W., Means T.K., Heldwein K.A., Keen M.A., Hill P.J., Belisle J.T.et al. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 69:2001;1036-1044.
13. Bulut Y., Faure E., Thomas L., Equils O., Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:2001;987-994.
14. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B.et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97:2000;13766-13771.
15. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z.Y.et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:2002;10-14.
16. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A. et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9:2003;525-532.
17. Kamath A.B., Alt J., Debbabi H., Behar S.M. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect. Immun. 71:2003;4112-4118.
18. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S.et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:2002;3480-3484.
19. Sugawara I., Yamada H., Li C., Mizuno S., Takeuchi O., Akira S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47:2003;327-336.
20. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M.et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:1999;811-815.
21. Henneke P., Takeuchi O., Malley R., Lien E., Ingalls R.R., Freeman M.W. et al. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol. 169:2002;3970-3977.
22. Aliprantis A.O., Weiss D.S., Zychlinsky A. Toll-like receptor-2 transduces signals for NF-kappa B activation, apoptosis and reactive oxygen species production. J. Endotoxin. Res. 7:2001;287-291.
23. Gao J.J., Zuvanich E.G., Xue Q., Horn D.L., Silverstein R., Morrison D.C. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J. Immunol. 163:1999;4095-4099.
24. Becker M.N., Diamond G., Verghese M.W., Randell S.H. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275:2000;29731-29736.
25. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F.et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:2001;863-869.
26. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppacciaro A., Mancinelli R.et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164:2000;5998-6004.
27. Thoma-Uszynski S., Kiertscher S.M., Ochoa M.T., Bouis D.A., Norgard M.V., Miyake K.et al. Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165:2000;3804-3810.
28. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G.et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:2001;6957-6966.
29. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J.et al. The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J. Biol. Chem. 276:2001;25680-25686.
30. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A.et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect. Immun. 68:2000;6883-6890.
31. Sieling P.A., Chung W., Duong B.T., Godowski P.J., Modlin R.L. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J. Immunol. 170:2003;194-200.
32. Giacomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G.et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166:2001;7033-7041.
33. Roach D.R., Bean A.G., Demangel C., France M.P., Briscoe H., Britton W.J. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168:2002;4620-4627.
34. Roach D.R., Briscoe H., Saunders B., France M.P., Riminton S., Britton W.J. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J. Exp. Med. 193:2001;239-246.
35. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J.et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:1995;561-572.
36. Bodnar K.A., Serbina N.V., Flynn J.L. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69:2001;800-809.
37. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M.et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5752-5757.
38. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T.et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263.
39. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:2001;947-950.
40. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T.et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:2001;910-918.
41. Pai R.K., Convery M., Hamilton T.A., Boom W.H., Harding C.V. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171:2003;175-184.
42. Repique C.J., Li A., Brickey W.J., Ting J.P., Collins F.M., Morris S.L. Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis. Scand. J. Immunol. 58:2003;15-22.
43. Engele M., Stossel E., Castiglione K., Schwerdtner N., Wagner M., Bolcskei P.et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 168:2002;1328-1337.
44. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B.et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:2003;7-17.
45. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:2001;7477-7485.
46. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. U.S.A. 100:2003;5437-5442.
47. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:2002;554-561.
48. Droemann D., Goldmann T., Branscheid D., Clark R., Dalhoff K., Zabel P., Vollmer E. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem. Cell Biol. 119:2003;103-108.
49. Takeuchi J., Watari E., Shinya E., Norose Y., Matsumoto M., Seya T.et al. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 306:2003;674-679.
50. Baker B.S., Ovigne J.M., Powles A.V., Corcoran S., Fry L. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br. J. Dermatol. 148:2003;670-679.
51. Ragno S., Estrada-Garcia I., Butler R., Colston M.J. Regulation of macrophage gene expression by Mycobacterium tuberculosis: Down-regulation of mitochondrial cytochrome c oxidase. Infect. Immun. 66:1998;3952-3958.
52. Stenger S., Niazi K.R., Modlin R.L. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 161:1998;3582-3588.
53. Wang T.Y., Lafuse W.P., Zwilling B.S. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 165:2000;6308-6313.
54. Oliveira R.B., Ochoa M.T., Sieling P.A., Rea T.H., Rambukkana A., Sarno E.N.et al. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect. Immun. 71:2003;1427-1433.
55. Guerardel Y, Maes E, Briken V, Chirat F, Leroy Y, Locht C, et al. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J Biol Chem 2003.
56. Bhattacharyya A., Pathak S., Basak C., Law S., Kundu M., Basu J. Execution of macrophage apoptosis by Mycobacterium avium through apoptosis signal-regulating kinase 1/p38 mitogen-activated protein kinase signaling and caspase 8 activation. J. Biol. Chem. 278:2003;26517-26525.
57. Hernandez M.O., Neves I., Sales J.S., Carvalho D.S., Sarno E.N., Sampaio E.P. Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha. Immunology. 109:2003;156-164.
58. Riendeau C.J., Kornfeld H. THP-1 cell apoptosis in response to Mycobacterial infection. Infect. Immun. 71:2003;254-259.
59. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D.et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science. 285:1999;736-739.
60. Aliprantis A.O., Yang R.B., Weiss D.S., Godowski P., Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19:2000;3325-3336.
61. Schmitt C., Humeny A., Becker C.M., Brune K., Pahl A. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin. Chem. 48:2002;1661-1667.
62. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68:2000;6398-6401.
63. Kang T.J., Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. Fems. Immunol. Med. Microbiol. 31:2001;53-58.
64. Kang T.J., Lee S.B., Chae G.T. A polymorphism in the Toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine. 20:2002;56-62.